Hughes Financial Services »

Kalvista Pharmaceuticals shares owned by Hughes Financial Services

Quarter-by-quarter ownership of Kalvista Pharmaceuticals (KALV) shares owned by Hughes Financial Services from 13F filings

Historical chart of Hughes Financial Services investment in Kalvista Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Kalvista Pharmaceuticals held by Hughes Financial Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kalvista Pharmaceuticals by Hughes Financial Services

Quarter filed Position value Share count Share price at filing
2026-03-31 $81 4 20.25
2025-12-31 $16 1 16.00

More positions owned by Hughes Financial Services

State Street Spdr Portfolio S&p 1500 Composite Stock Market Etf Etf (SPTM)
Jpmorgan Core Plus Bond Etf Etf (JCPB)
Jpmorgan International Research Enhanced Equity Etf Etf (JIRE)
Jpmorgan U.s. Quality Factor Etf Etf (JQUA)
Ishares Msci Emerging Markets Ex China Etf Etf (EMXC)
Ishares Core Dividend Growth Etf Etf (DGRO)
Jpmorgan U.s. Tech Leaders Etf Etf (JTEK)
Jpmorgan International Bond Opportunities Fund Etf (JPIB)
State Street Spdr Portfolio Tips Etf Etf (SPIP)
Ishares 1-3 Year Treasury Bond Etf Etf (SHY)
Ishares Msci Usa Quality Factor Etf Etf (QUAL)
Dimensional U.s. Equity Market Etf Etf (DFUS)
Ishares 10-20 Year Treasury Bond Etf Etf (TLH)
Vanguard Short-term Tax Exempt Bond Etf Etf (VTES)
State Street Spdr Msci Usa Strategicfactors Etf Etf (QUS)

View all positions for Hughes Financial Services

Top funds holding Kalvista Pharmaceuticals

VR Adviser
Frazier Life Sciences Management
Suvretta Capital Management
Tang Capital Management
BlackRock
Capital World Investors
Vanguard Group
Silverarc Capital Management
Point72 Asset Management
Millennium Management
State Street Corporation
Vestal Point Capital
Vanguard Capital Management
Kynam Capital Management
Parkman Healthcare Partners

View all funds holding Kalvista Pharmaceuticals